Skip to main content
. 2025 Apr 28;26(9):4167. doi: 10.3390/ijms26094167
amyloid-β
aCSF artificial cerebrospinal fluid
AD Alzheimer’s disease
ALDH1L1 aldehyde dehydrogenase 1 family member L1
AUC area under the receiver operating characteristic
AUCCi 95% confidence interval of the AUC
BSA bovine serum albumin
CD11b cluster of differentiation 11b
CD45 cluster of differentiation 45
CD163 cluster of differentiation 163
DAM disease-associated microglia
DMEM Dulbecco’s Modified Eagle Medium
DMSO dimethyl sulfoxide
EDTA ethylenediaminetetraacetic acid
EL escape latency
F4/80 EMR1 (EGF-like module-containing-mucin-like hormone receptor-like 1)
FACS fluorescence-activated cell sorting
fEPSP field excitatory postsynaptic potential
GFAP glial fibrillary acidic protein
HBSS Hanks’ Balanced Salt Solution
IL-1β interleukin-1β
LTP long-term potentiation
P2RY12 purinergic receptor P2Y12
PBS phosphate-buffered saline
PFA paraformaldehyde
TG transgenic
TMEM119 transmembrane protein 119
TREM-2 triggering receptor expressed on myeloid cells 2
WCM water cross maze
WT wildtype